|
Mata, Douglas A; Groshen, Susan; Von Rundstedt, Friedrich-Carl et al. (2015) Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 111:923-8
|
|
von Rundstedt, Friedrich-Carl; Mata, Douglas A; Groshen, Susan et al. (2015) Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial. BJU Int 116:44-9
|
|
Stadler, Walter M; Lerner, Seth P; Groshen, Susan et al. (2011) Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. J Clin Oncol 29:3443-9
|
|
Bartsch, Georg; Mitra, Anirban P; Cote, Richard J (2010) Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10:1945-54
|
|
George, Ben; Datar, Ram H; Wu, Lin et al. (2007) p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. J Clin Oncol 25:5352-8
|
|
Birkhahn, Marc; Mitra, Anirban P; Cote, Richard J (2007) Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev Anticancer Ther 7:1717-27
|
|
Mitra, Anirban P; Birkhahn, Marc; Cote, Richard J (2007) p53 and retinoblastoma pathways in bladder cancer. World J Urol 25:563-71
|
|
Gonzalgo, Mark L; Datar, Ram H; Schoenberg, Mark P et al. (2007) The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer. Urol Oncol 25:228-35
|
|
Mitra, Anirban P; Datar, Ram H; Cote, Richard J (2006) Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24:5552-64
|
|
Mitra, Anirban P; Lin, Henry; Datar, Ram H et al. (2006) Molecular biology of bladder cancer: prognostic and clinical implications. Clin Genitourin Cancer 5:67-77
|
Showing the most recent 10 out of 28 publications
